Atrys Health, S.A. (ATRY.MC)

EUR 2.88

(1.77%)

Gross Profit Summary of Atrys Health, S.A.

Atrys Health, S.A.'s latest annual gross profit in 2023 was 52.61 Million EUR , down -79.59% from previous year.
Atrys Health, S.A.'s latest quarterly gross profit in 2024 Q2 was 13.37 Million EUR , down -21.34% from previous quarter.
Atrys Health, S.A. reported a annual gross profit of 154.51 Million EUR in annual gross profit 2022, up 53.15% from previous year.
Atrys Health, S.A. reported a annual gross profit of 100.89 Million EUR in annual gross profit 2021, up 316.04% from previous year.
Atrys Health, S.A. reported a quarterly gross profit of 13.37 Million EUR for 2024 Q2, down -21.34% from previous quarter.
Atrys Health, S.A. reported a quarterly gross profit of 17.93 Million EUR for 2023 Q1, up 63.41% from previous quarter.

Annual Gross Profit Chart of Atrys Health, S.A. (2023 - 2012)

Historical Annual Gross Profit of Atrys Health, S.A. (2023 - 2012)

Year	Gross Profit	Gross Profit Growth
2023	52.61 Million EUR	-79.59%
2022	154.51 Million EUR	53.15%
2021	100.89 Million EUR	316.04%
2020	24.25 Million EUR	98.82%
2019	12.19 Million EUR	77.49%
2018	6.87 Million EUR	16.59%
2017	5.89 Million EUR	32.64%
2016	4.44 Million EUR	110.95%
2015	2.1 Million EUR	2308.59%
2014	87.45 Thousand EUR	109.43%
2013	-927.05 Thousand EUR	-0.13%
2012	-925.81 Thousand EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	17 Million EUR	59.11%
2024 Q2	13.37 Million EUR	-21.34%
2023 Q1	17.93 Million EUR	63.41%
2023 Q4	10.68 Million EUR	0.49%
2023 FY	31.54 Million EUR	-79.59%
2023 Q3	10.63 Million EUR	-48.99%
2023 Q2	20.85 Million EUR	16.27%
2022 Q2	21.46 Million EUR	37.48%
2022 FY	154.51 Million EUR	53.15%
2022 Q3	19.12 Million EUR	-10.91%
2022 Q1	15.61 Million EUR	328.88%
2022 Q4	10.97 Million EUR	-42.6%
2021 Q4	-6.82 Million EUR	-171.1%
2021 Q2	9.45 Million EUR	26.1%
2021 Q3	9.59 Million EUR	1.45%
2021 FY	100.89 Million EUR	316.04%
2021 Q1	7.49 Million EUR	58.35%
2020 FY	24.25 Million EUR	98.82%
2020 Q2	1.46 Million EUR	-0.0%
2020 Q1	1.46 Million EUR	-53.34%
2020 Q3	4.73 Million EUR	223.39%
2020 Q4	4.73 Million EUR	0.0%
2019 Q4	3.13 Million EUR	46.27%
2019 Q2	1.93 Million EUR	43.96%
2019 Q3	2.14 Million EUR	10.92%
2019 Q1	1.34 Million EUR	-29.23%
2019 FY	12.19 Million EUR	77.49%
2018 Q1	1.01 Million EUR	-2.41%
2018 FY	6.87 Million EUR	16.59%
2018 Q4	1.89 Million EUR	89.7%
2018 Q3	1 Million EUR	-35.89%
2018 Q2	1.56 Million EUR	53.92%
2017 Q4	1.03 Million EUR	0.0%
2017 FY	5.89 Million EUR	32.64%
2017 Q2	753.96 Thousand EUR	0.0%
2017 Q1	753.96 Thousand EUR	27.74%
2017 Q3	1.03 Million EUR	37.87%
2016 Q1	626.12 Thousand EUR	0.0%
2016 Q2	626.12 Thousand EUR	-0.0%
2016 FY	4.44 Million EUR	110.95%
2016 Q4	590.21 Thousand EUR	0.0%
2016 Q3	590.21 Thousand EUR	-5.74%
2015 FY	2.1 Million EUR	2308.59%
2014 FY	87.45 Thousand EUR	109.43%
2013 FY	-927.05 Thousand EUR	-0.13%
2012 FY	-925.81 Thousand EUR	0.0%

Peer Gross Profit Comparison of Atrys Health, S.A.

Name	Gross Profit	Gross Profit Difference
Biotechnologies Assets SA	3.45 Million EUR	-1421.585%
Oryzon Genomics S.A.	13.94 Million EUR	-277.218%
Pharma Mar, S.A.	148.54 Million EUR	64.579%
Laboratorios Farmaceuticos Rovi, S.A.	492.28 Million EUR	89.312%